Discrimination against drug addicts that suffer with an addiction, only a few will receive treatment due to the complexity of health care systems. Most health care systems do not have insurance coverage for addiction recovery and many health care providers have little to no training in treating addiction. Some doctors do not feel comfortable treating an addiction due to their lack of knowledge and training of the topic. This is one of the reasons why drug dependence is difficult to recover from. Among injecting drug users, the incidence of HIV infection is higher than among other drug addicts, however punitive and discriminatory measures against
Testolactone Testolactone Testolactone (, ) (brand name Teslac) is a non-selective, irreversible, steroidal aromatase inhibitor which is used as an antineoplastic drug to treat advanced-stage breast cancer. The drug was discontinued in 2008 and is no longer available for medical use. However, it has been reported to still be marketed in the United States by Bristol-Myers Squibb under the brand name Teslac. This drug is mainly used for treating various types of breast cancer in women who have been through menopause or whose ovaries no longer function. It works by blocking the production of estrogen, which helps prevent the growth of